Syndax Pharmaceuticals SNDX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's free cash flow margin?
- Syndax Pharmaceuticals (SNDX) reported free cash flow margin of -187.2% in Q4 2025.
- How has Syndax Pharmaceuticals's free cash flow margin changed year-over-year?
- Syndax Pharmaceuticals's free cash flow margin increased by 83.9% year-over-year, from -1,160.9% to -187.2%.
- What is the long-term trend for Syndax Pharmaceuticals's free cash flow margin?
- Over 3 years (2020 to 2025), Syndax Pharmaceuticals's free cash flow margin has grown at a -65.8% compound annual growth rate (CAGR), from -4,697.4% to -187.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.